AMRX Other Income/Expenses (Net)
Amneal Pharmaceuticals Inc Class A · Other Income/Expenses (Net)
AMRX Other Income/Expenses (Net)
Latest reported-$74.99Mperiod ending
AMRX Quarterly Other Income/Expenses (Net) (-$36.51M → -$74.99M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
AMRX other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -74,990,000 | |
| -62,694,000 | |
| -59,267,000 | |
| -5,106,000 | |
| -59,661,000 | |
| -62,861,000 | |
| -91,112,000 | |
| -73,386,000 | |
| -75,065,000 | |
| -64,776,000 | |
| -97,654,000 | |
| -52,691,000 | |
| -50,424,000 | |
| -43,875,000 | |
| -43,687,000 | |
| -42,173,000 | |
| -34,113,000 | |
| -33,226,000 | |
| -27,494,000 | |
| -30,558,000 | |
| -32,295,000 | |
| -31,003,000 | |
| -25,655,000 | |
| -24,324,000 | |
| -32,509,000 | |
| -44,447,000 | |
| -33,976,000 | |
| 138,550,000 | |
| -37,314,000 | |
| -38,820,000 | |
| -38,086,000 | |
| -51,981,000 | |
| -81,444,000 | |
| -11,538,000 | |
| -16,944,000 | |
| -52,369,000 | |
| -5,003,000 | |
| 536,000 | |
| -36,513,000 |